Behavioral, Physiological and Biochemical Hormetic Responses to the Autoxidizable Dye Methylene Blue.

The goals of this review were to identify methylene blue (MB) as a compound that follows hormetic behavior for a wide range of effects and to address the question of what is unique about MB that could account for its wide applicability and hormetic behavior as a drug. The MB hormetic dose-response relationship is exemplified by an increase in various behavioral, physiological and biochemical responses with increasing dose, followed by a decrease in the same responses with an even higher dose, until the responses are equal to control responses. With MB doses increasing beyond the hormetic zone, the responses decrease even further, until they are below the control responses. At doses spanning its hormetic zone, MB can increase select responses until they are 130-160% of control. For example, low doses of MB produce maximum behavioral and biochemical responses with averages of approximately 140% of control. As MB dose is raised outside the hormetic zone the response decreases below the control response, as exemplified by MB's ability to increase cytochrome oxidase activity at intermediate doses, while decreasing cytochrome oxidase activity at higher doses. It is proposed that MB's autoxidizable chemical property may be responsible for its unique biological action as both a metabolic energy enhancer and antioxidant that is frequently characterized by hormetic dose-response relationships.

[1]  A Scott,et al.  Support of thyroxine-induced swelling of liver mitochondria by generation of high energy intermediates at any one of three sites in electron transport. , 1966, The Journal of biological chemistry.

[2]  W. Clark,et al.  Studies on Oxidation-Reduction: VIII. Methylene Blue , 1925 .

[3]  F Gonzalez-Lima,et al.  Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption. , 2005, European journal of pharmacology.

[4]  F. Guimarães,et al.  Anxiolytic effect of methylene blue microinjected into the dorsal periaqueductal gray matter. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[5]  F Gonzalez-Lima,et al.  Extinction memory improvement by the metabolic enhancer methylene blue. , 2004, Learning & memory.

[6]  C. Agnisola,et al.  Evidence for NO-dependent vasodilation in the trout (Oncorhynchus mykiss ) coronary system , 1997, Journal of Comparative Physiology B.

[7]  A. Weinbroum,et al.  Methylene blue attenuates lung injury after mesenteric artery clamping/unclamping , 2004, European journal of clinical investigation.

[8]  M. Kelner,et al.  Potential of methylene blue to block oxygen radical generation in reperfusion injury. , 1988, Basic life sciences.

[9]  M. Wainwright,et al.  Methylene Blue - a Therapeutic Dye for All Seasons? , 2002, Journal of chemotherapy.

[10]  M. Pfaffendorf,et al.  The interaction between methylene blue and the cholinergic system , 1997, British journal of pharmacology.

[11]  J. Leikin,et al.  Methylene blue , 2021, ASHP® Injectable Drug Information™.

[12]  A. Pakarinen,et al.  Effects of Drugs on Clinical Laboratory Tests , 1997, Annals of clinical biochemistry.

[13]  C. Babbs,et al.  Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. , 1991, Biochemical pharmacology.

[14]  G. Burrows Methylene blue: effects and disposition in sheep. , 1984, Journal of veterinary pharmacology and therapeutics.

[15]  C. Dawson,et al.  Reduction of thiazine dyes by bovine pulmonary arterial endothelial cells in culture. , 1995, The American journal of physiology.

[16]  F. Gonzalez-Lima,et al.  Methylene blue improves brain oxidative metabolism and memory retention in rats , 2004, Pharmacology Biochemistry and Behavior.

[17]  J. Stucki,et al.  Stimulation of respiration by methylene blue in rat liver mitochondria , 1997, FEBS letters.

[18]  D. Santani,et al.  A novel use of methylene blue as a pharmacological tool. , 2006, Journal of pharmacological and toxicological methods.

[19]  B. Mayer,et al.  Novel actions of methylene blue. , 1993, European heart journal.

[20]  C. E. Cobb,et al.  Reduction and uptake of methylene blue by human erythrocytes. , 2004, American journal of physiology. Cell physiology.

[21]  P. Gillman,et al.  Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction , 2007, British journal of pharmacology.

[22]  A. Sidi,et al.  Blue dyes, blue people: the systemic effects of blue dyes when administered via different routes. , 2007, Journal of clinical anesthesia.

[23]  M. Roth,et al.  Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Wong-Riley Cytochrome oxidase: an endogenous metabolic marker for neuronal activity , 1989, Trends in Neurosciences.

[25]  F. Gonzalez-Lima,et al.  Methylene blue prevents neurodegeneration caused by rotenone in the retina , 2009, Neurotoxicity Research.

[26]  J. Cragan Teratogen update: methylene blue. , 1999, Teratology.

[27]  Takeshi Iwatsubo,et al.  Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins* , 2005, Journal of Biological Chemistry.

[28]  G. Dawson,et al.  Use of the elevated plus maze in the search for novel anxiolytic agents. , 1995, Trends in pharmacological sciences.

[29]  David L. McCollum,et al.  Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats , 2002, Neuroscience Letters.

[30]  A. Szold,et al.  Methylene Blue in Preventing Hemodynamic and Metabolic Derangement Following Superior Mesenteric Artery Clamping/Unclamping: An Intratracheal vs. Intraperitoneal Dose-Response Study , 2002, Shock.

[31]  Kathleen A. Boyle,et al.  Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  L. Eroǧlu,et al.  Anxiolytic and antidepressant properties of methylene blue in animal models. , 1997, Pharmacological research.

[33]  Edward J Calabrese,et al.  Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. , 2007, Toxicology and applied pharmacology.

[34]  D. Young,et al.  Effects of drugs on clinical laboratory tests. , 1972, Clinical chemistry.

[35]  D. Schrijvers,et al.  Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature , 2000, British Journal of Cancer.

[36]  James L. McGaugh,et al.  Methylene blue alters retention of inhibitory avoidance responses , 1978 .

[37]  L. Breydo,et al.  Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. , 2007, Biochemistry.

[38]  P. Rosenberg,et al.  Methylene blue adjuvant therapy of schizophrenia. , 1997, Clinical neuropharmacology.

[39]  G. Naylor,et al.  A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manicdepressive psychosis , 1986, Biological Psychiatry.